The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2022

Filed:

May. 03, 2018
Applicants:

Sreenivasarao Vepachedu, Vernon Hills, IL (US);

Exciva Gmbh, Vernon Hills, IL (US);

Inventors:

Sreenivasarao Vepachedu, Vernon Hills, IL (US);

Hans J Moebius, Wollerau, CH;

Anton Bespalov, Heidelberg, DE;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4748 (2006.01); A61K 31/662 (2006.01); A61K 31/222 (2006.01); A61K 31/225 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4748 (2013.01); A61K 31/222 (2013.01); A61K 31/225 (2013.01); A61K 31/662 (2013.01);
Abstract

Compounds of Formula I, pharmaceutically acceptable salts thereof, enantiomers thereof, metabolites thereof, derivatives thereof, prodrugs thereof, acid addition salts thereof, pharmaceutically acceptable salts thereof, or N-oxides thereof; or a combination thereof; processes and intermediates for preparation thereof, compositions thereof, and uses thereof; are provided. Pharmaceutical compositions comprising a compound of Formula I, or enantiomers thereof, metabolites thereof, derivatives thereof, prodrugs thereof, acid addition salts thereof, pharmaceutically acceptable salts thereof, or N-oxides thereof; or a combination thereof; wherein the compound is a double and/or triple agent or ligand for CYP2D6, 5-HT2A, and/or 5HT2C receptors, and/or acetylcholinesterase are provided.


Find Patent Forward Citations

Loading…